Zahid Q. Bonday, Guillermo S. Cortez, Michael J. Grogan, Stephen Antonysamy, Ken Weichert, Thomas J. Raub, Wayne P. Bocchinfuso, Fengling Li, Steven Kennedy, Binghui Li, Mary M. Mader, Cheryl H. Arrowsmith, Robert M. Campbell, Peter J. Brown, Mohammad S. Eram, Magdalena M. Szewczyk, Masoud Vedadi, Dalia Barsyte-Lovejoy. LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with antitumor activity. ACS Med. Chem. Lett. (2018) DOI: 10.1021/acsmedchemlett.8b00014